日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy of paclitaxel-carboplatin with bevacizumab as a late-line therapy for patients with advanced nonsquamous non-small cell lung cancer: A platinum rechallenge

紫杉醇-卡铂联合贝伐单抗作为晚期非鳞状非小细胞肺癌患者一线治疗的疗效：铂类药物再挑战

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15107
Sugisaka, Jun; Toi, Yukihiro; Kawashima, Yosuke; Domeki, Yutaka; Aiba, Tomoiki; Kawana, Sachiko; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancer

免疫相关性肺炎与晚期非小细胞肺癌抗程序性细胞死亡蛋白-1单药治疗的临床获益相关

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.4045
Ono, Kana; Ono, Hirotaka; Toi, Yukihiro; Sugisaka, Jun; Aso, Mari; Saito, Ryohei; Kawana, Sachiko; Aiba, Tomoiki; Odaka, Tetsuo; Matsuda, Suguru; Saito, Shin; Narumi, Akane; Ogasawara, Takahiro; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Kawashima, Yosuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro; Sugawara, Shunichi
肺炎
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer

晚期非小细胞肺癌患者接受抗程序性细胞死亡蛋白1单药治疗时，皮肤反应与临床获益之间的关联

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0550
Aso, Mari; Toi, Yukihiro; Sugisaka, Jun; Aiba, Tomoiki; Kawana, Sachiko; Saito, Ryohei; Ogasawara, Takahiro; Tsurumi, Kyoji; Ono, Kana; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Kawashima, Yosuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro; Sugawara, Shunichi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab

程序性细胞死亡蛋白配体 1 表达与接受帕博利珠单抗治疗的非小细胞肺癌患者免疫相关不良事件之间的关系

期刊:JMA Journal
影响因子:1.8
doi:10.31662/jmaj.2019-0005
Sugisaka, Jun; Toi, Yukihiro; Taguri, Masataka; Kawashima, Yosuke; Aiba, Tomoiki; Kawana, Sachiko; Saito, Ryohei; Aso, Mari; Tsurumi, Kyoji; Suzuki, Kana; Shimizu, Hisashi; Ono, Hirotaka; Domeki, Yutaka; Terayama, Keisuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro; Sugawara, Shunichi
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2020
文献求助 收藏

Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer

对接受抗PD-1疗法治疗的晚期非小细胞肺癌患者体内预先存在的抗体进行分析

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2018.5860
Toi, Yukihiro; Sugawara, Shunichi; Sugisaka, Jun; Ono, Hirotaka; Kawashima, Yosuke; Aiba, Tomoiki; Kawana, Sachiko; Saito, Ryohei; Aso, Mari; Tsurumi, Kyoji; Suzuki, Kana; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro
肺癌
肿瘤
肿瘤免疫
细胞生物学
PD-1
发表日期：2019
文献求助 收藏

Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab

免疫相关不良事件与接受纳武利尤单抗治疗的晚期非小细胞肺癌患者的临床获益之间的关联

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2017-0384
Toi, Yukihiro; Sugawara, Shunichi; Kawashima, Yosuke; Aiba, Tomoiki; Kawana, Sachiko; Saito, Ryohei; Tsurumi, Kyoji; Suzuki, Kana; Shimizu, Hisashi; Sugisaka, Jun; Ono, Hirotaka; Domeki, Yutaka; Terayama, Keisuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2018
文献求助 收藏

Effectiveness of proton beam therapy on liver metastases of esophageal cancer: report of a case

质子束疗法治疗食管癌肝转移的疗效：一例报告

期刊:
影响因子:
doi:10.9738/INTSURG-D-13-00188.1
Muroi, Hiroto; Nakajima, Masanobu; Satomura, Hitoshi; Takahashi, Masakazu; Domeki, Yasushi; Murakami, Masao; Nakamura, Tatsuya; Takada, Akinori; Kato, Hiroyuki
食管癌
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

Phase I Dose-Escalation Study of Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients With Advanced Esophageal Carcinoma

多西他赛、顺铂和5-氟尿嘧啶联合化疗治疗晚期食管癌患者的I期剂量递增研究

期刊:
影响因子:
doi:10.9738/INTSURG-D-14-00233.1
Satomura, Hitoshi; Nakajima, Masanobu; Sasaki, Kinro; Yamaguchi, Satoru; Domeki, Yasushi; Takahashi, Masakazu; Muroi, Hiroto; Kubo, Tsukasa; Kikuchi, Maiko; Otomo, Haruka; Ihara, Keisuke; Kato, Hiroyuki
食管癌
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus

一项关于2型糖尿病患者使用预混胰岛素赖脯胰岛素50/50与门冬胰岛素70/30进行阶梯式治疗的随机试验

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-014-0078-7
Domeki, Nozomi; Matsumura, Mihoko; Monden, Tsuyoshi; Nakatani, Yuki; Aso, Yoshimasa
代谢
糖尿病
免疫/内分泌
发表日期：2014
文献求助 收藏

Salvage lymphadenectomy for recurrent esophageal cancer after chemoradiotherapy

化疗放疗后食管癌复发的挽救性淋巴结切除术

期刊:
影响因子:
doi:10.9738/INTSURG-D-13-00261.1
Nakajima, Masanobu; Domeki, Yasushi; Satomura, Hitoshi; Takahashi, Masakazu; Sugawara, Akira; Muroi, Hiroto; Sasaki, Kinro; Yamaguchi, Satoru; Miyazaki, Tatsuya; Kuwano, Hiroyuki; Kato, Hiroyuki
食管癌
肿瘤
肿瘤免疫
发表日期：2014
文献求助 收藏